The regulation of human MMP-13 by licofelone, an inhibitor of cyclo-oxygenases and 5-lipoxygenase, in human osteoarthritic chondrocytes is mediated by the inhibition of the p38 MAP kinase signalling pathway

被引:49
作者
Boileau, C
Pelletier, JP
Tardif, G
Fahmi, H
Laufer, S
Lavigne, M
Martel-Pelletier, J
机构
[1] Univ Montreal, Notre Dame Hosp, Ctr Hosp, Osteoarthrit Res Unit, Montreal, PQ H2L 4M1, Canada
[2] Univ Tubingen, Tubingen, Germany
[3] Hop Maison Neuve Rosemont, Montreal, PQ H1T 2M4, Canada
关键词
D O I
10.1136/ard.2004.026906
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: MMP-13 is one of the most important metalloproteases (MMP) involved in osteoarthritis. Licofelone, a novel dual inhibitor of cyclo-oxygenases ( COX) and 5-lipoxygenase (5-LOX), can modulate MMP-13 production in human osteoarthritis chondrocytes. Objective: To evaluate the impact of licofelone on MMP-13 expression/production, promoter, and major MAP kinase signalling pathways and transcription factors. Methods: Human osteoarthritis chondrocytes were stimulated by interleukin 1 beta ( IL1 beta) and treated with or without: licofelone (0.3, 1, or 3 mg/ml); NS-398 ( 10 mu M; a specific COX-2 inhibitor); or BayX-1005 ( 10 mM; a specific 5-LOX inhibitor). MMP-13 synthesis was determined by specific enzyme linked immunosorbent assay, and expression by real time polymerase chain reaction. The effect of licofelone on the MMP-13 promoter was studied through transient transfection; dexamethasone ( 1027 M) was used as comparison. The effect on IL1 beta induced MMP-13 signalling pathways was determined using specific ELISA for phosphorylated MAP kinases and transcription factors. Results: Licofelone dose dependently inhibited the IL1 beta stimulated production and expression of MMP-13. NS-398 and BayX-1005 had very little effect. Licofelone also inhibited MMP-13 transcription on each of the promoter constructs used. The licofelone inhibition was comparable to that obtained with dexamethasone. Licofelone had no effect on phosphorylated p44/42 or JNK1/2; however, it decreased phosphorylated c-jun and inhibited phosphorylated p38, CREB, and AP-1 activity. Conclusions: Licofelone inhibited MMP-13 production under proinflammatory conditions on human osteoarthritis chondrocytes, through inhibition of the p38/AP-1 pathway and the transcription factor CREB. This may explain some of the mechanisms whereby licofelone exerts its positive effect on osteoarthritic changes.
引用
收藏
页码:891 / 898
页数:8
相关论文
共 55 条
[1]   DEVELOPMENT OF CRITERIA FOR THE CLASSIFICATION AND REPORTING OF OSTEOARTHRITIS - CLASSIFICATION OF OSTEOARTHRITIS OF THE KNEE [J].
ALTMAN, R ;
ASCH, E ;
BLOCH, D ;
BOLE, G ;
BORENSTEIN, D ;
BRANDT, K ;
CHRISTY, W ;
COOKE, TD ;
GREENWALD, R ;
HOCHBERG, M ;
HOWELL, D ;
KAPLAN, D ;
KOOPMAN, W ;
LONGLEY, S ;
MANKIN, H ;
MCSHANE, DJ ;
MEDSGER, T ;
MEENAN, R ;
MIKKELSEN, W ;
MOSKOWITZ, R ;
MURPHY, W ;
ROTHSCHILD, B ;
SEGAL, M ;
SOKOLOFF, L ;
WOLFE, F .
ARTHRITIS AND RHEUMATISM, 1986, 29 (08) :1039-1049
[2]  
Angel P, 1992, Matrix Suppl, V1, P156
[3]   BINDING OF AP-1/CREB PROTEINS AND OF MDBP TO CONTIGUOUS SITES DOWNSTREAM OF THE HUMAN TGF-BETA-1 GENE [J].
ASIEDU, CK ;
SCOTTO, L ;
ASSOIAN, RK ;
EHRLICH, M .
BIOCHIMICA ET BIOPHYSICA ACTA-GENE STRUCTURE AND EXPRESSION, 1994, 1219 (01) :55-63
[4]   The AP-1 site and MMP gene regulation: What is all the fuss about? [J].
Benbow, U ;
Brinckerhoff, CE .
MATRIX BIOLOGY, 1997, 15 (8-9) :519-526
[5]  
Benderdour M, 2002, J RHEUMATOL, V29, P1262
[6]   A novel negative regulatory element in the human collagenase-3 proximal promoter region [J].
Benderdour, M ;
Tardif, G ;
Pelletier, JP ;
Dupuis, M ;
Geng, C ;
Martel-Pelletier, J .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2002, 291 (05) :1151-1159
[7]  
Boileau C, 2002, J RHEUMATOL, V29, P1446
[8]  
Caron JP, 1996, AM J VET RES, V57, P1631
[9]   Anti-inflammatory drugs: New multitarget compounds to face an old problem. The dual inhibition concept [J].
Celotti, F ;
Laufer, S .
PHARMACOLOGICAL RESEARCH, 2001, 43 (05) :429-436
[10]   A cyclooxygenase-2 (COX-2) selective non-steroidal anti-inflammmatory drug enhances the growth inhibitory effect of butyrate in colorectal carcinoma cells expressing COX-2 protein: regulation of COX-2 by butyrate [J].
Crew, TE ;
Elder, DJE ;
Paraskeva, C .
CARCINOGENESIS, 2000, 21 (01) :69-77